BrainCool secures external financing of up to SEK 100 million and issues free warrants to its shareholders
BrainCool AB (publ) ("BrainCool") has signed an agreement relating to an investment of up to SEK 100 million. The capital will be used for launching BrainCool’s products in the US. The transaction is carried out through a private placement of convertible notes (the “Notes”) with warrants attached (the “Warrants”) in several tranches spread over 36 months (each, a “Tranche”). CEO Martin Waleij comments; -BrainCool has had a strong development. Based on our unique technology and innovative product development, we have created a broad portfolio of medical cooling products that have the